由于高血糖血症引起的缺血性中风:解开分子机制和治疗视野
Bin Li1, Yushun Kou1, Lingna Zhang1
1School of Traditional Chinese and Western Medicine Gansu University of Chinese Medicine Lanzhou China.
Food science & nutrition
|July 4, 2025
概括
增加的同类氨酸水平 (高同类氨酸血) 是缺血性中风的重要危险因素. 了解它的机制和探索维生素补充剂可能有助于预防和治疗策略.
科学领域:
- 神经学 神经学
- 生物化学 生物化学
- 心血管医学 心血管医学
背景情况:
- 同类氨酸是一种有毒的甲氨酸代谢中间体.
- 损坏的同型氨酸代谢会导致高同型氨酸血,这是缺血性中风的危险因素.
研究的目的:
- 审查将高同胞蛋白血症与缺血性中风联系在一起的机制.
- 分析与高homocysteinemia相关的缺血性中风的预防和治疗策略.
主要方法:
- 关于高血糖蛋白质血症机制研究的综述.
- 对高血糖蛋白血症的遗传和营养原因的分析.
- 检查病理过程:炎症,氧化应激,神经毒性,表观遗传失调.
- 对预防中风的维生素补充的临床试验的审查.
主要成果:
- 超homocysteinemia是由酶基因突变或辅助因子缺乏导致的.
- 病理途径包括血管损伤,血栓形成和血管收缩.
- 维生素补充试验显示了部分,异质的预防证据.
结论:
- 过高homocysteinemia通过多种生物机制导致缺血性中风.
- 对于新的治疗方法和有效的预防策略,需要进一步的研究.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
919
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
919
Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Hypertension II: Pathophysiology
90
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
90
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
222
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
222
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
49
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
49
Extrinsic and Intrinsic Pathways of Hemostasis
9.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.3K


